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Background
Several studies highlight the implication of nitric oxide
(NO) in the airways inflammation during asthma. More-
over, asthma is thought to be associated with a systemic
inflammation. However, little is known about the systemic
production of NO in asmathic patients. In this sense, our
aim was to evaluate the in vivo and ex vivo production of
NO in Algerian patients with severe asthma. Moreover, the
effect of helminthes infection on asthma is still inconclu-
sive. In this sense, the second part of this study aims to
investigate the effect of the helminth Echinococcus granu-
losus on this production. This parasite causes cyst forma-
tion particularly in lungs and liver.
Method
The NO production was evaluated in sera and culture per-
formed with mononuclear cells (PBMC) from asthmatic
patients and healthy donors. We have also investigated the
effect of laminated layer extract (LLs, outside layer of para-
sitic cyst) on NO production by the same cells.
Results
We observed that in vivo and ex vivo NO levels assessed
in patients with severe asthma are higher than those
observed in healthy donors. Interestingly, we found that
LLs reduced NO production ex vivo. This result was
confirmed using L-NMMA, an inhibitor of nitric oxide
synthases (NOS).
Conclusion
Our data confirm the implication of NO in the pathogen-
esis of severe asthma. They also support the hypothesis
that helminthes infection prevents and/or modulates
inflammation during inflammatory diseases like asthma.
The potentiel effect of laminated layer to reduce the
inflammation in the airways and to reduce the risk of
severe asthma remains to be investigated in mouse model
of asthma.
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